Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for healthcare industry professionals · Tuesday, April 23, 2024 · 706,000,217 Articles · 3+ Million Readers

TELSTAR SUPPLIES AN INSTALLATION OF 95m3 AUTOCLAVES FOR STERILIZATION OF LARGE VOLUME PARENTERAL SOLUTIONS

An unit of 95 m3 autoclave for sterilization of large volume parenteral solutions

The seven-effect water still with a capacity for up to 12,000 litres/hour of distilled water (WFI)

For Laboratorios Pisa, the leading pharmaceutical and medical devices manufacturer in Latin America.

The autoclave installation, together with seven-effect water stills and high capacity steam generators, form part of the production line at the Laboratorios Pisa plant in Guadalajara (Mexico)
— -
TERRASSA, BARCELONA, SPAIN, July 29, 2014 /EINPresswire.com/ -- Telstar has supplied a set of autoclaves for sterilization of large volume parenteral solutions and isotonic liquid products to the pharmaceutical firm Laboratorios Pisa. The autoclaves have been installed at the Mexican group’s pharmaceutical plant in Tlajomulco, Guadalajara (Mexico). This supply contract for multiple pieces of equipment, which was delivered in December 2013, is to be extended by the addition of further autoclaves during 2014.

The super-heated water autoclaves developed by Telstar for Laboratorios Pisa, which can perform faster and more energy-efficient sterilisation cycles, are characterized by their large capacity. Each autoclave has been specially designed for use in sterilization process of large batches of parenteral solutions. Control systems have been included which can compensate the pressure differences occurring between the inside of the container and the autoclave chamber during the heating and cooling phases. This system ensures that the processes occur at controlled temperature and that the physical integrity of the container is retained at the end of the cycle.

Telstar is also supplying the Laboratorios Pisa plant in Guadalajara with several seven-effect water stills, each with a capacity for up to 12,000 litres/hour of distilled water (WFI); some of which are in full operation and a further two which are now in the process of manufacture. The seven-effect stills operate without requiring any cooling water. The seven columns provide more enhanced utilization of the heating energy and as a result in the last condensation phase no cooling water intake is required. This represents a significant financial saving considering such large production volumes.

The autoclaves and water stills developed by Telstar for the Laboratorios Pisa pharmaceutical plant in Guadalajara are complemented by steam generators, each with a capacity for 1,000 kg/hour of pure steam.

Freeze-drying 500,000 vials/month of solutions-for-injection

Also, during the course of 2014, Telstar will supply steam sterilizable freeze dryer capacity for the production of injectable products at Laboratorios Pisa’s plant in Tlajomulco, Guadalajara. With a freeze-drying surface area of 19.8m2, each piece of equipment has the capacity to freeze-dry a total of 33,000 vials every 40 hour cycle over 15 cycles a month.

Furthermore, two steam autoclaves for terminal sterilization of blisters and culture media manufactured by Telstar will be supplied to the plant located in the industrial area of Guadalajara, which Laboratorios Pisa uses for developing process improvements.

Laboratorios Pisa

Laboratorios Pisa is the leading pharmaceutical and medical devices manufacturer in Latin America. It was founded in 1945, and supplies medicines and medical equipment to both the public and private health and hospitals market, particularly solutions-for-injection, formulas for artificial nutrition, oral rehydration, medicines for cancer, anaesthesiology and antibiotics. The group has a professional team of 14,000 employees, 17 lines of pharmaceutical specialities, more than 900 products and also its own distribution network.

Marketing Dept
Telstar
+34 93 736 16 00
email us here

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release